![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Breast Cancer |
Free Subscription
2 AJR Am J Roentgenol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Breast Cancer is free of charge.
Expanding Biopsy Options for Suspicious Breast Lesions: CT-Guided Biopsy Using a
3D-Printed Device.
AJR Am J Roentgenol. 2023 Jul 5:1-2. doi: 10.2214/AJR.23.29421.
PubMed
Reply to: "Expanding Biopsy Options for Suspicious Breast Lesions: CT-Guided
Biopsy Using a 3D-Printed Device".
AJR Am J Roentgenol. 2023 Jul 5:2. doi: 10.2214/AJR.23.29476.
PubMed
Computer Vision Identifies Recurrent and Nonrecurrent Ductal Carcinoma in Situ
Lesions with Special Emphasis on African-American Women.
Am J Pathol. 2023;193:1195-1207.
PubMed
Abstract available
Metabolome Sequencing Reveals that Protein Arginine-N-Methyltransferase 1
Promotes the Progression of Invasive Micropapillary Carcinoma of the Breast and
Predicts a Poor Prognosis.
Am J Pathol. 2023;193:1267-1283.
PubMed
Abstract available
Circulating tumor DNA association with residual cancer burden after neoadjuvant
chemotherapy in triple-negative breast cancer in TBCRC 030.
Ann Oncol. 2023 Aug 17:S0923-7534(23)00801-3. doi: 10.1016/j.annonc.2023.
PubMed
Abstract available
Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant
metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial.
Ann Oncol. 2023 Aug 17:S0923-7534(23)00800-1. doi: 10.1016/j.annonc.2023.
PubMed
Abstract available
Great Debate: The Surgeon's Role in Locoregional Management of Stage IV Breast
Cancer.
Ann Surg Oncol. 2023 Aug 19. doi: 10.1245/s10434-023-14134.
PubMed
ASO Visual Abstract: Enhanced Surgical Decision-Making Tools in Breast
Cancer-Predicting 2-Year Postoperative Physical, Sexual, and Psychosocial
Well-Being Following Mastectomy and Breast Reconstruction (INSPiRED 004).
Ann Surg Oncol. 2023 Aug 19. doi: 10.1245/s10434-023-14095.
PubMed
ASO Visual Abstract: A Randomized Trial Comparing the Effectiveness of Pre-test
Genetic Counseling Using an Artificial Intelligence Automated Chatbot and
Traditional In-person Genetic Counseling in Women Newly Diagnosed with Breast
Cancer.
Ann Surg Oncol. 2023 Aug 21. doi: 10.1245/s10434-023-13989.
PubMed
ASO Visual Abstract: Extremely Low Incidence of Local-Regional Recurrences
Observed among T1-2N1 (one or two Positive SLNs) Breast Cancer Patients Receiving
Upfront Mastectomy without Completion Axillary Node Dissection.
Ann Surg Oncol. 2023 Aug 23. doi: 10.1245/s10434-023-14088.
PubMed
ASO Author Reflections: Breast Cancer-Related Lymphedema (BCRL) Surveillance
Recommendations with Bioimpedance Spectroscopy.
Ann Surg Oncol. 2023 Aug 23. doi: 10.1245/s10434-023-14099.
PubMed
Surgical Management of the Axilla in HR+/HER2- Breast Cancer in the Z1071 Era: A
Propensity Score-Matched Analysis of the National Cancer Database.
Ann Surg Oncol. 2023 Aug 23. doi: 10.1245/s10434-023-14029.
PubMed
Abstract available
ASO Author Reflections: Low Rates of Local-Regional Recurrence in Inflammatory
Breast Cancer Patients After Contemporary Trimodal Therapy.
Ann Surg Oncol. 2023 Aug 23. doi: 10.1245/s10434-023-14159.
PubMed
Intraoperative Ultrasound-Guided Conserving Surgery for Breast Cancer: No More
Time for Blind Surgery.
Ann Surg Oncol. 2023 Aug 22. doi: 10.1245/s10434-023-13900.
PubMed
Abstract available
A Novel Injection Protocol Using Voluven(R)-Assisted Indocyanine Green with
Improved Near-Infrared Fluorescence Guidance in Breast Cancer Sentinel Lymph Node
Mapping-A Translational Study.
Ann Surg Oncol. 2023 Aug 21. doi: 10.1245/s10434-023-14129.
PubMed
Abstract available
Effect of Delayed Oncoplastic Reduction Mammoplasty on Radiation Treatment Delay
Following Breast-Conserving Surgery for Breast Cancer.
Ann Surg Oncol. 2023 Aug 21. doi: 10.1245/s10434-023-14177.
PubMed
Abstract available
A novel super-enhancer-related gene signature predicts prognosis and immune
microenvironment for breast cancer.
BMC Cancer. 2023;23:776.
PubMed
Abstract available
Neoadjuvant immunotherapy and chemotherapy regimens for the treatment of
high-risk, early-stage triple-negative breast cancer: a systematic review and
network meta-analysis.
BMC Cancer. 2023;23:792.
PubMed
Abstract available
Neo-train: study protocol and feasibility results for a two-arm randomized
controlled trial investigating the effect of supervised exercise during
neoadjuvant chemotherapy on tumour response in patients with breast cancer.
BMC Cancer. 2023;23:777.
PubMed
Abstract available
Pathological complete response, category change, and prognostic significance of
HER2-low breast cancer receiving neoadjuvant treatment: a multicenter analysis of
2489 cases.
Br J Cancer. 2023 Aug 21. doi: 10.1038/s41416-023-02403.
PubMed
Abstract available
Assessment of nuclear grade-based recurrence risk classification in patients with
hormone receptor-positive, human epidermal growth factor receptor 2-negative,
node-positive high-risk early breast cancer.
Breast Cancer. 2023 Aug 23. doi: 10.1007/s12282-023-01500.
PubMed
Abstract available
Reply to "Is venous thromboembolism a time-dependent event in breast cancer
patients taking tamoxifen?".
Breast Cancer. 2023 Aug 21. doi: 10.1007/s12282-023-01495.
PubMed
Breast Cancer (Dove Med Press)
Risk of Subsequent Breast Cancer in Women with Early Stage HER2-Positive Breast
Cancer in a Large Community Health Plan.
Breast Cancer (Dove Med Press). 2023;15:637-645.
PubMed
Abstract available
Diagnostic Value of a Combined Serum alpha-Hydroxybutyrate Dehydrogenase,
Carcinoembryonic Antigen and Glycoantigen 125 Test for Early-Stage Breast Cancer.
Breast Cancer (Dove Med Press). 2023;15:617-623.
PubMed
Abstract available
HER2-Low Breast Cancer: Current Landscape and Future Prospects.
Breast Cancer (Dove Med Press). 2023;15:605-616.
PubMed
Abstract available
Correction: Long noncoding RNA PVT1 promotes breast cancer proliferation and
metastasis by binding miR-128-3p and UPF1.
Breast Cancer Res. 2023;25:98.
PubMed
FGF1 supports glycolytic metabolism through the estrogen receptor in
endocrine-resistant and obesity-associated breast cancer.
Breast Cancer Res. 2023;25:99.
PubMed
Abstract available
Head-to-head comparison of contrast-enhanced mammography and contrast-enhanced
MRI for assessing pathological complete response to neoadjuvant therapy in
patients with breast cancer: a meta-analysis.
Breast Cancer Res Treat. 2023 Aug 24. doi: 10.1007/s10549-023-07034.
PubMed
Abstract available
Frequency of germline pathogenic variants in breast cancer predisposition genes
among young Turkish breast cancer patients.
Breast Cancer Res Treat. 2023 Aug 24. doi: 10.1007/s10549-023-07074.
PubMed
Abstract available
Electro-acupuncture versus battle field auricular acupuncture in breast cancer
survivors with chronic musculoskeletal pain: subgroup analysis of a randomized
clinical trial.
Breast Cancer Res Treat. 2023 Aug 24. doi: 10.1007/s10549-023-07072.
PubMed
Abstract available
Pan-cancer analysis of G6PD carcinogenesis in human tumors.
Carcinogenesis. 2023;44:525-534.
PubMed
Abstract available
Monitoring of Triple Negative Breast Cancer After Neoadjuvant Chemotherapy.
Clin Breast Cancer. 2023 Aug 5:S1526-8209(23)00208.
PubMed
Abstract available
MicroRNA-143-5p Suppresses ER-Positive Breast Cancer Development by Targeting
Oncogenic HMGA2.
Clin Breast Cancer. 2023 Aug 3:S1526-8209(23)00207.
PubMed
Abstract available
Keeping it in the family: HER3 as a target in brain metastases.
Clin Cancer Res. 2023 Jun 12:CCR-23-1107. doi: 10.1158/1078-0432.CCR-23-1107.
PubMed
Abstract available
FDA Approval Summary: Ribociclib Indicated for Male Patients with Hormone
Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer.
Clin Cancer Res. 2023 Aug 18:CCR-23-1133. doi: 10.1158/1078-0432.CCR-23-1133.
PubMed
Abstract available
Noninvasive identification of HER2-low-positive status by MRI-based deep learning
radiomics predicts the disease-free survival of patients with breast cancer.
Eur Radiol. 2023 Aug 19. doi: 10.1007/s00330-023-09990.
PubMed
Abstract available
Breast cancer diagnosis from contrast-enhanced mammography using multi-feature
fusion neural network.
Eur Radiol. 2023 Aug 23. doi: 10.1007/s00330-023-10170.
PubMed
Abstract available
Diagnostic performance of MRI for assessing axillary lymph node status after
neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis.
Eur Radiol. 2023 Aug 24. doi: 10.1007/s00330-023-10155.
PubMed
Abstract available
A mutator-derived prognostic eRNA signature provides insight into the
pathogenesis of breast cancer.
Exp Cell Res. 2023 Aug 21:113754. doi: 10.1016/j.yexcr.2023.113754.
PubMed
Abstract available
Ki67 assessment protocol as an integral biomarker for avoiding radiotherapy in
the LUMINA breast cancer trial.
Histopathology. 2023 Aug 23. doi: 10.1111/his.15032.
PubMed
Abstract available
Adding fasting-mimicking diet to first-line carboplatin-based chemotherapy is
associated with better overall survival in advanced triple-negative breast cancer
patients: A subanalysis of the NCT03340935 trial.
Int J Cancer. 2023 Aug 24. doi: 10.1002/ijc.34701.
PubMed
Abstract available
Lnc‑RGS5 sponges miR‑542‑5p to promote FoxM1/VEGFA signaling and breast cancer
cell proliferation.
Int J Oncol. 2023;63:111.
PubMed
Abstract available
Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone
Receptor-Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the
ASTRRA Trial.
J Clin Oncol. 2023 Aug 22:JCO2300557. doi: 10.1200/JCO.23.00557.
PubMed
Abstract available
De Novo Oligometastatic Breast Cancer.
J Clin Oncol. 2023 Aug 22:JCO2300911. doi: 10.1200/JCO.23.00911.
PubMed
Contralateral breast cancer risk with radiation therapy in BRCA mutation
carriers: what do we tell patients?
J Natl Cancer Inst. 2023 Aug 21:djad129. doi: 10.1093.
PubMed
Spatial analyses of immune cell infiltration in cancer: current methods and
future directions. A report of the International Immuno-Oncology Biomarker
Working Group on Breast Cancer.
J Pathol. 2023 Aug 23. doi: 10.1002/path.6165.
PubMed
Abstract available
Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes
in breast cancer: a report of the international immuno-oncology biomarker working
group.
J Pathol. 2023 Aug 23. doi: 10.1002/path.6155.
PubMed
Abstract available
A Deep Learning Approach for Histology-Based Nucleus Segmentation and Tumor
Microenvironment Characterization.
Mod Pathol. 2023;36:100196.
PubMed
Abstract available
Author Correction: Combining the AKT inhibitor capivasertib and SERD fulvestrant
is effective in palbociclib-resistant ER+ breast cancer preclinical models.
NPJ Breast Cancer. 2023;9:69.
PubMed
Adverse kidney outcomes of CDK 4/6 inhibitors for metastatic breast cancer.
NPJ Breast Cancer. 2023;9:70.
PubMed
Abstract available
ICAM2 initiates trans-blood-CSF barrier migration and stemness properties in
leptomeningeal metastasis of triple-negative breast cancer.
Oncogene. 2023 Jul 19. doi: 10.1038/s41388-023-02769.
PubMed
Abstract available
[Retracted] MicroRNA‑1297 contributes to tumor growth of human breast cancer by
targeting PTEN/PI3K/AKT signaling.
Oncol Rep. 2023;50:180.
PubMed
Abstract available
Results of a Phase Ib Study Investigating Durvalumab in Combination with Eribulin
in Patients with HER2-negative Metastatic Breast Cancer and Recurrent Ovarian
Cancer.
Oncology. 2023 Aug 18. doi: 10.1159/000533420.
PubMed
Abstract available
Adjuvant therapeutic strategy decision support for an elderly population with
localized breast cancer: A monocentric cohort retrospective study.
PLoS One. 2023;18:e0290566.
PubMed
Abstract available
Cost-effectiveness of trastuzumab deruxtecan for previously treated HER2-low
advanced breast cancer.
PLoS One. 2023;18:e0290507.
PubMed
Abstract available
Patient satisfaction of breast reconstructive surgery following mastectomy in
Brunei.
PLoS One. 2023;18:e0289955.
PubMed
Abstract available
MLK4 as an immune marker and its correlation with immune infiltration in Cervical
squamous cell carcinoma and endocervical adenocarcinoma(CESC).
PLoS One. 2023;18:e0290462.
PubMed
Abstract available
Safety profile of trastuzumab-emtansine (T-DM1) with concurrent radiation
therapy: A systematic review and meta-analysis.
Radiother Oncol. 2023;186:109805.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by